Sumitomo Dainippon Pharma Co. Ltd. (TYO:4506) announced on Sep. 1, 2016, that its U.S. subsidiary Sunovion Pharmaceuticals Inc. will acquire…...

Japan's leading chemical industry newspaper

Filed Under: Pharma, Products Tagged With: Cynapsus Therapeutics, FDA, Parkinson’s disease, Sumitomo Dainippon Pharma, Sunovion Pharmaceuticals
Sumitomo Dainippon Pharma Co. Ltd. (TYO:4506) announced on Sep. 1, 2016, that its U.S. subsidiary Sunovion Pharmaceuticals Inc. will acquire…...